-
Signature
-
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kirsten M. Kliphouse
-
Issuer symbol
-
LH
-
Transactions as of
-
11 Feb 2025
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
13 Feb 2025, 08:17:17 UTC
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
LH |
Restricted Stock Unit |
Award |
$0 |
+897 |
|
$0.000000 |
897 |
11 Feb 2025 |
Common Stock |
897 |
|
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
On May 17, 2024, LHI became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.